11 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

#o

#f

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y
5/15/24 17:49
5/13/24
MYGNMyriad Genetics IncDEHealthDiagnIn Vitro & In Vivo Diagnostic22S.m-5,88625.150-2341,133D
5/15/24 17:09
5/13/24
LNTHLantheus Holdings, Inc.DEHealthDiagnIn Vitro & In Vivo Diagnostic510S.dm-10,75257.850-186968D
5/8/24 19:02
5/6/24
IDXXIdexx Laboratories Inc /deDEHealthDiagnIn Vitro & In Vivo Diagnostic1013M.d9,385425.790223747D
4/26/24 12:50
4/25/24
NEOGNeogen CorpMIHealthDiagnIn Vitro & In Vivo Diagnostic57M.d70412.4605725280D
4/23/24 16:39
4/19/24
ACHVAchieve Life Sciences, Inc.DEHealthDiagnIn Vitro & In Vivo Diagnostic46M.d921.0308992187D
4/16/24 18:18
4/12/24
QDELQuidelortho CorpHealthDiagnIn Vitro & In Vivo Diagnostic22M.d29025.930111490D
4/15/24 19:21
4/11/24
OCXOncocyte CorpCAHealthDiagnIn Vitro & In Vivo Diagnostic33P.d7,1682.9202,457339,946D
4/8/24 15:28
3/31/24
CDIOCardio Diagnostics Holdings, Inc.DEHealthDiagnIn Vitro & In Vivo Diagnostic44M.d501.4203516252D
3/8/24 11:24
3/6/24
CATXPerspective Therapeutics, Inc.DEHealthDiagnIn Vitro & In Vivo Diagnostic11P57,4090.9500060,431107116,773D
3/5/24 16:10
3/4/24
NTLAIntellia Therapeutics, Inc.DEHealthDiagnIn Vitro & In Vivo Diagnostic22S.d-9632.990-3153D
2/27/24 16:21
8/15/22
TKNOAlpha Teknova, Inc.DEHealthDiagnIn Vitro & In Vivo Diagnostic11P.m505.37099D

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact